These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13970828)

  • 1. [Fibrinolytic activity and anticoagulant drugs].
    BERKARDA B
    Turk Tip Cemiy Mecm; 1963 Mar; 29():135-8. PubMed ID: 13970828
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANTICOAGULANTS IN THE TREATMENT AND PROPHYLAXIS OF PULMONARY EMBOLISM].
    RIOSMOZO M; ZAMORAMADARIA E
    Hisp Med; 1963 Aug; 20():449-60. PubMed ID: 14091450
    [No Abstract]   [Full Text] [Related]  

  • 3. Variation in fibrinolytic activity after acute myocardial infarction and after the administration of oral anticoagulant drugs and intravenous heparin.
    LACKNER H; MERSKEY C
    Br J Haematol; 1960 Oct; 6():402-13. PubMed ID: 13758090
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE TREATMENT OF MYOCARDIAL INFARCT WITH ANTICOAGULANTS].
    REMDE W
    Z Arztl Fortbild (Jena); 1963 Nov; 57():1237-42. PubMed ID: 14116146
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of the fibrinolytic activity after a single heparin load in atherosclerosis].
    JANIAKOWA A
    Pol Arch Med Wewn; 1960; 30():987-9. PubMed ID: 13789398
    [No Abstract]   [Full Text] [Related]  

  • 6. [Initial experiences with fibrinolytic therapy of acute myocardial infarct].
    POLIWODA H; SCHOEDER R; HECKNER F
    Dtsch Med J; 1963 Feb; 88():218-24. PubMed ID: 13971974
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin versus heparin-bishydroxycoumarin anticoagulant therapy: comparison in patients with acute complicated myocardial infarction.
    GRIFFITH GC; ZINN WJ; ENGELBERG H; DOOLEY JV; ANDERSON R
    JAMA; 1960 Oct; 174():1157-60. PubMed ID: 13708590
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of heparin and bishydroxycoumarin (dicumarol) as anticoagulants; resistance to tissue thromboplastin.
    BELKO JS; WARREN R
    AMA Arch Surg; 1957 Jan; 74(1):50-8. PubMed ID: 13381297
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant therapy. I.
    KUPFER HG
    Va Med Mon (1918); 1963 Mar; 90():143-4. PubMed ID: 13927435
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of continuous long-term heparin and oral anticoagulant therapy in patients with severe angina pectoris.
    HUGHES ML; MORTENSEN F; SHOURIE L
    Am Heart J; 1963 May; 65():615-27. PubMed ID: 13955568
    [No Abstract]   [Full Text] [Related]  

  • 11. HEPARIN VERSUS ORAL ANTICOAGULANT THERAPY IN CORONARY ATHEROSCLEROSIS: REVIEW OF ADVANTAGES AND DISADVANTAGES.
    HUGHES ML; MORTENSEN F; SHOURIE L
    South Med J; 1964 Mar; 57():292-6. PubMed ID: 14128542
    [No Abstract]   [Full Text] [Related]  

  • 12. [ENDOGENOUS FIBRINOLYTIC POTENTIAL AND ITS STIMULATION BY A POLYSACCHARIDE ESTER].
    HALSE D
    Hemostase; 1963; 3():149-64. PubMed ID: 14050812
    [No Abstract]   [Full Text] [Related]  

  • 13. A COMPARISON OF WARFARIN SODIUM AND BISHYDROXYCOUMARIN IN LONG-TERM ANTICOAGULANT THERAPY.
    BROWN KW; MACMILLAN RL
    Can Med Assoc J; 1964 Dec; 91(26):1358-9. PubMed ID: 14230912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous trypsin; its anticoagulant, fibrinolytic and thrombolytic effects.
    INNERFIELD I; SCHWARZ A; ANGRIST A
    J Clin Invest; 1952 Dec; 31(12):1049-55. PubMed ID: 13011195
    [No Abstract]   [Full Text] [Related]  

  • 15. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
    CLIFFTON EE
    Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticoagulant medication and venous thrombosis].
    MERZ WR; BOSSART H
    Rev Med Suisse Romande; 1962 Sep; 82():531-7. PubMed ID: 13935090
    [No Abstract]   [Full Text] [Related]  

  • 17. [MYOCARDIAL INFARCT AND THROMBOSIS IN PRACTICE. AMBULANT ANTICOAGULANT THERAPY AND CONTROL OF DEVELOPMENTS. CENTRAL THROMBOSIS SERVICES].
    EDAM K
    Med Welt; 1964 Apr; 16():910-5. PubMed ID: 14196333
    [No Abstract]   [Full Text] [Related]  

  • 18. THE SURGICAL PATIENT ON ANTICOAGULANT THERAPY.
    OWEN CA; SPITTELL JA; THOMPSON JH
    Am J Cardiol; 1963 Sep; 12():309-12. PubMed ID: 14064845
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of anticoagulant substances (dicumarol and heparin) in the prevention of the local Shwartzman reaction.
    EICHBAUM FW
    J Allergy; 1957 Sep; 28(5):429-35. PubMed ID: 13462687
    [No Abstract]   [Full Text] [Related]  

  • 20. [SKIN NECROSES IN ANTICOAGULANT THERAPY].
    STACHER A
    Wien Z Inn Med; 1964 Feb; 45():47-9. PubMed ID: 14155957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.